Prevalence and clinical outcomes of fibrotic interstitial lung disease in ANCA associated vasculitis: a single-centre, retrospective, cohort study

ANCA相关性血管炎合并纤维化间质性肺疾病的患病率和临床结局:一项单中心回顾性队列研究

阅读:1

Abstract

BACKGROUND: Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) may affect multiple organs and interstitial lung disease (ILD) might be the first manifestation. Limited and discordant data are available on the prevalence of ILD in patients with AAV. Little is known about prognostic outcomes of these patients. The primary aim of the study was to determine the prevalence of fibrotic ILD in a cohort of AAV patients followed-up in a University Hospital in Italy. Clinical and prognostic outcomes of AAV-ILD were also assessed. METHODS: Data from 71 AAV patients (mean age 60.3 ± 16 years; female 58.9%) were retrospectively collected and analyzed. RESULTS: Overall ILD prevalence was 50.7%. Fibrotic ILDs represented 32.4% with a variable distribution according to AAV diagnosis: microscopic polyangiitis (MPA) 66.7%, eosinophilic granulomatosis with polyangiitis (EGPA) 41.1%, granulomatosis with polyangiitis (GPA) 31.8%. The presence of ILD was significantly different across AAV subgroups. Fibrotic ILD was more prevalent in MPA (60%) than EGPA (11.8%) and GPA (9.1%) and most frequently associated with usual interstitial pneumonia (UIP) radiologic pattern. The presence of ANCA was significantly associated with fibrotic ILDs (p = 0.01). In univariate analysis, only MPA increased the risk of having ILD (OR 2 (CI 95%: 0.96–4.67). Mortality was significantly higher in patients with ILD (p = 0.01), with fibrotic forms influencing this finding and MPA showing the highest mortality. CONCLUSIONS: Fibrotic ILDs are common in patients with AAV and influence clinical and prognostic outcomes. MPA is the most frequent AAV associated to fibrotic ILD. ILD should be investigated at diagnosis in all patients with AAV, since early detection might impact the prognosis of these patients.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。